Pear Therapeutics – Medical Alley Association

Pear Therapeutics

PEAR THERAPEUTICS AND PRESCRYPTIVE HEALTH ANNOUNCE FORMULARY COVERAGE FOR PRESCRIPTION DIGITAL THERAPEUTICS RESET® & RESET-O® FOR THE TREATMENT OF SUBSTANCE AND OPIOID USE DISORDERS

BOSTON, SAN FRANCISCO, and REDMOND, Wash., April 1, 2021 – Pear Therapeutics, Inc. and Prescryptive Health today announced that Prescryptive, the first health intelligence platform, will offer and administer benefit coverage for reSET® and reSET-O®, the first two prescription digital therapeutics (PDTs) to receive authorization from the U.S. Food and Drug Administration (FDA) to treat disease. reSET and reSET-O have been […]

For the Record with Julia Strandberg, Chief Commercial Officer, Pear Therapeutics

Give us Pear Therapeutics’ elevator pitch. At Pear, we are creating Prescription Digital Therapeutics (PDTs), the next generation of therapeutics that use software to directly treat serious disease, alone or in combination with drugs, allowing for optimized, remote care at scale. We sit at the nexus of biotech, tech and medical device, with the aim to redefine […]

Keep your finger on the pulse of Medical Alley from anywhere with the ALLEY NEWSLETTER